SynthesisMedicine2020

Comparative efficacy and safety of sunitinib vs sorafenib in renal cell carcinoma: A systematic review and meta-analysis.

Xiu-Lan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.